Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.

Van Damme P, Leroux-Roels G, Vandermeulen C, De Ryck I, Tasciotti A, Dozot M, Moraschini L, Testa M, Arora AK.

Vaccine. 2019 May 21;37(23):3113-3122. doi: 10.1016/j.vaccine.2019.04.041. Epub 2019 Apr 24.

2.

Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.

Bona G, Castiglia P, Zoppi G, de Martino M, Tasciotti A, D'Agostino D, Han L, Smolenov I.

Vaccine. 2016 Jun 17;34(29):3363-70. doi: 10.1016/j.vaccine.2016.05.009. Epub 2016 May 12.

3.

POPs in free-ranging pilot whales, sperm whales and fin whales from the Mediterranean Sea: Influence of biological and ecological factors.

Pinzone M, Budzinski H, Tasciotti A, Ody D, Lepoint G, Schnitzler J, Scholl G, Thomé JP, Tapie N, Eppe G, Das K.

Environ Res. 2015 Oct;142:185-96. doi: 10.1016/j.envres.2015.06.021. Epub 2015 Jul 8.

PMID:
26162962
4.

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.

Catania C, Maur M, Berardi R, Rocca A, Giacomo AM, Spitaleri G, Masini C, Pierantoni C, González-Iglesias R, Zigon G, Tasciotti A, Giovannoni L, Lovato V, Elia G, Menssen HD, Neri D, Cascinu S, Conte PF, Braud Fd.

Cell Adh Migr. 2015;9(1-2):14-21. doi: 10.4161/19336918.2014.983785.

5.

Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.

Spitaleri G, Berardi R, Pierantoni C, De Pas T, Noberasco C, Libbra C, González-Iglesias R, Giovannoni L, Tasciotti A, Neri D, Menssen HD, de Braud F.

J Cancer Res Clin Oncol. 2013 Mar;139(3):447-55. doi: 10.1007/s00432-012-1327-7. Epub 2012 Nov 17.

PMID:
23160853
6.

Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma.

Papadia F, Basso V, Patuzzo R, Maurichi A, Di Florio A, Zardi L, Ventura E, González-Iglesias R, Lovato V, Giovannoni L, Tasciotti A, Neri D, Santinami M, Menssen HD, De Cian F.

J Surg Oncol. 2013 Feb;107(2):173-9. doi: 10.1002/jso.23168. Epub 2012 Jun 4.

PMID:
22674435
7.

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

Eigentler TK, Weide B, de Braud F, Spitaleri G, Romanini A, Pflugfelder A, González-Iglesias R, Tasciotti A, Giovannoni L, Schwager K, Lovato V, Kaspar M, Trachsel E, Menssen HD, Neri D, Garbe C.

Clin Cancer Res. 2011 Dec 15;17(24):7732-42. doi: 10.1158/1078-0432.CCR-11-1203. Epub 2011 Oct 25.

8.

Fractal analysis of fluoroangiographic patterns in anterior ischaemic optic neuropathy and optic neuritis: a pilot study.

Traversi C, Bianciardi G, Tasciotti A, Berni E, Nuti E, Luzi P, Tosi GM.

Clin Exp Ophthalmol. 2008 May;36(4):323-8. doi: 10.1111/j.1442-9071.2008.01766.x.

PMID:
18700918

Supplemental Content

Loading ...
Support Center